Research funding. A framework for decisions about research with HPAI H5N1 viruses
- PMID: 23429700
- PMCID: PMC4011183
- DOI: 10.1126/science.1236194
Research funding. A framework for decisions about research with HPAI H5N1 viruses
Abstract
The U.S. Department of Health and Human Services unveils a Framework for funding decisions about highly pathogenic avian influenza H5N1 research.
Comment in
-
Biosecurity's weakest link.Science. 2013 Apr 12;340(6129):141-2. doi: 10.1126/science.340.6129.141-b. Science. 2013. PMID: 23580509 No abstract available.
Similar articles
-
Biosecurity's weakest link.Science. 2013 Apr 12;340(6129):141-2. doi: 10.1126/science.340.6129.141-b. Science. 2013. PMID: 23580509 No abstract available.
-
The H5N1 moratorium controversy and debate.mBio. 2012 Nov 1;3(5):e00379-12. doi: 10.1128/mBio.00379-12. mBio. 2012. PMID: 23047753 Free PMC article. No abstract available.
-
Research on highly pathogenic H5N1 influenza virus: the way forward.mBio. 2012 Nov 1;3(5):e00359-12. doi: 10.1128/mBio.00359-12. mBio. 2012. PMID: 23047751 Free PMC article.
-
Egyptian H5N1 influenza viruses-cause for concern?PLoS Pathog. 2012;8(11):e1002932. doi: 10.1371/journal.ppat.1002932. Epub 2012 Nov 15. PLoS Pathog. 2012. PMID: 23166487 Free PMC article. Review. No abstract available.
-
Molecular pathogenesis of H5N1 influenza virus infections.Antivir Ther. 2007;12(4 Pt B):617-26. Antivir Ther. 2007. PMID: 17944269 Review.
Cited by
-
Reconsidering the need for gain-of-function research on enhanced potential pandemic pathogens in the post-COVID-19 era.Front Bioeng Biotechnol. 2022 Aug 26;10:966586. doi: 10.3389/fbioe.2022.966586. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 36091454 Free PMC article.
-
Surveillance of laboratory exposures to human pathogens and toxins: Canada 2018.Can Commun Dis Rep. 2019 Sep 5;45(9):244-251. doi: 10.14745/ccdr.v45i09a04. eCollection 2019 Sep 5. Can Commun Dis Rep. 2019. PMID: 31650987 Free PMC article.
-
Evaluating interest in an influenza A(H5N1) vaccine among laboratory workers who work with highly-pathogenic avian influenza viruses in the United States.Vaccine. 2018 Jan 4;36(2):306-312. doi: 10.1016/j.vaccine.2017.10.104. Epub 2017 Dec 2. Vaccine. 2018. PMID: 29199043 Free PMC article.
-
Nasal delivery of Protollin-adjuvanted H5N1 vaccine induces enhanced systemic as well as mucosal immunity in mice.Vaccine. 2017 Jun 5;35(25):3318-3325. doi: 10.1016/j.vaccine.2017.05.004. Epub 2017 May 9. Vaccine. 2017. PMID: 28499553 Free PMC article.
-
Gain-of-Function Research and the Relevance to Clinical Practice.J Infect Dis. 2016 May 1;213(9):1364-9. doi: 10.1093/infdis/jiv473. Epub 2015 Sep 27. J Infect Dis. 2016. PMID: 26416657 Free PMC article. Review.
References
-
- Food and Agriculture Organization. H5N1 Highly Pathogenic Avian Influenza—Global Overview. FAO; Rome: 2012. www.fao.org/docrep/015/an388e/an388e.pdf.
-
- Centers for Disease Control and Prevention. Highly Pathogenic Avian Influenza A (H5N1) in People. www.cdc.gov/flu/avianflu/h5n1-people.htm.
-
- Fouchier RAM, García-Sastre A, Kawaoka Y. Nature. 2012;481:443. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
